TEL AVIV, Israel, Feb. 07, 2019 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it will host a conference call and webcast on Tuesday, February 19, […]
Author: Ken Dropiewski
New Patent Issuances Strengthen InCarda Therapeutics’ Intellectual Property Portfolio Covering Novel Inhaled Cardiovascular Therapies
SAN FRANCISCO, Feb. 07, 2019 (GLOBE NEWSWIRE) — InCarda Therapeutics, Inc. (“InCarda”), a privately-held biopharmaceutical company developing first-of-their-kind inhaled therapies for cardiovascular diseases, today announced that new U.S. patents have been issued by the U.S. Patent and Trademark Office (USPTO). The two new patents provide the company with significantly expanded […]
Correvio Announces Presentation Of Brinavess Data At Belgian Society Of Cardiology 2019 Annual Congress
VANCOUVER, Feb. 7, 2019 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced the presentation of clinical data highlighting the low rate of hospitalization in patients treated with Brinavess® (vernakalant hydrochloride, IV), its antiarrhythmic drug for the rapid conversion of recent onset atrial […]
Medtronic Receives FDA Approval on Expanded Indication for Pipeline Flex Embolization Device
DUBLIN – February 7, 2019 – Medtronic plc (NYSE:MDT) announced today that it has received U.S. Food and Drug Administration (FDA) approval on an expanded indication for its Pipeline(TM) Flex embolization device.1 Previously indicated for the endovascular treatment of adults with large or giant wide-necked intracranial aneurysms (IAs) in the internal carotid […]
VentureMed Group Names J. Robert Paulson Jr. Chief Executive Officer
Toledo, Ohio, February 5, 2019 – VentureMed Group, Inc., a privately-held medical device company that develops and markets the FLEX Vessel Prep™ System to treat peripheral arterial disease (PAD) and stenoses of arteriovenous (AV) fistulas and grafts, announced today that J. Robert Paulson, Jr., has been appointed president and chief […]
Confluent Medical Technologies Launches the High-Performance Nitinol Tubing Center of Excellence; Acquires Tube Hollows International (THI) to Now Offer the Most Comprehensive Selection of Nitinol Tubing for High-Performance Implants.
FREMONT, Calif.–(BUSINESS WIRE)–Confluent Medical (formerly Nitinol Devices & Components “NDC”) launched today the High-Performance Nitinol Tubing Center of Excellence in response to increasing market demand for High-Performance Nitinol Tubing in challenging applications such as Transcatheter Heart Valves, Neurovascular, Electrophysiology, and Interventional Pulmonary. Confluent Medical is able to support the Nitinol […]
Omron Healthcare and physIQ Partner to Transform Cardiovascular Patient Care
CHICAGO–(BUSINESS WIRE)–Omron Healthcare, Inc. and physIQ Inc. today announced a collaboration to integrate Omron’s innovative FDA-cleared device, HeartGuide®, the first wearable blood pressure monitor into the pinpointIQ®platform to monitor at-risk patients in an outpatient setting. The strategic collaboration aims to generate actionable clinical information for at-risk patients in an outpatient environment by leveraging […]
Quantum Genomics Announces the Publication of Two Scientific Articles Confirming the Efficacy of Firibastat for Heart Failure
PARIS and NEW YORK, Feb. 06, 2019 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat resistant hypertension and heart failure, announces the publication of two new scientific articles on the […]
Arterys Named to the 2019 CB Insights AI 100 List
SAN FRANCISCO, Feb. 6, 2019 /PRNewswire/ — Arterys, the leader in intelligent, cloud-based medical image analysis software, today announced that it has been named for the second consecutive year to CB Insights’ coveted AI 100 ranking, which showcases the 100 most promising private artificial intelligence (AI) companies in the world. Arterys was recognized for its […]
Boston Scientific Announces Results For Fourth Quarter And Full Year 2018
MARLBOROUGH, Mass., Feb. 6, 2019 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales of $2.561 billion during the fourth quarter of 2018. This represents growth of 6.3 percent on a reported basis, 8.2 percent on an operational1 basis and 7.0 percent on an organic2 basis, all compared to the prior year period. The company reported […]



